|
Caspase-4 (active) (human) (recombinant) |
|
|
ALX-201-093-U025 |
|
25 U |
203.00 USD |
|
 |
|
ALX-201-093-U100 |
|
100 U |
371.00 USD |
|
|
|
|
PDIA2 (human) (recombinant) |
|
|
ALX-201-152-C025 |
|
25 µg |
155.00 USD |
|
|
|
|
BiP (mouse) (recombinant) |
|
|
ALX-201-219-C025 |
|
25 µg |
170.00 USD |
|
|
|
|
Calnexin (dog) (recombinant) |
|
|
ALX-201-220-C025 |
|
25 µg |
170.00 USD |
|
|
|
|
Calreticulin (rabbit) (recombinant) |
|
|
ALX-201-269-C025 |
|
25 µg |
170.00 USD |
|
|
|
|
Polyclonal Antibody to TRAF2 (human) (Bur 34) |
|
|
ALX-210-024-R050 |
|
50 µl |
190.00 USD |
|
|
|
|
Polyclonal Antibody to TRAF2 (mouse) (AR-63) |
|
|
ALX-210-029-R050 |
|
50 µl |
190.00 USD |
|
|
|
|
Polyclonal Antibody to Calreticulin |
|
|
ALX-210-126-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Polyclonal Antibody to BiP |
|
|
ALX-210-137/1-C100 |
|
100 µg |
379.00 USD |
|
|
|
|
Polyclonal Antibody to Calreticulin (NT) |
|
|
ALX-210-170/1-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Polyclonal Antibody to Calreticulin (CT) |
|
|
ALX-210-171-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Polyclonal Antibody to ERp29 |
|
|
ALX-210-404-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Polyclonal Antibody to ERp57 (human) |
|
|
ALX-210-405-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Polyclonal Antibody to ERp72 (human) |
|
|
ALX-210-406-C100 |
|
100 µg |
379.00 USD |
|
|
|
|
Polyclonal Antibody to Caspase-4 |
|
|
ALX-210-808-C100 |
|
100 µg |
357.00 USD |
|
|
|
|
Polyclonal Antibody to PDIA6 (human) |
|
|
ALX-210-889-R100 |
|
100 µl |
379.00 USD |
|
|
|
|
Salubrinal |
|
|
ALX-270-428-M001 |
|
1 mg |
30.00 USD |
|
|
|
ALX-270-428-M005 |
|
5 mg |
110.00 USD |
|
|
|
|
Thapsigargin |
|
|
ALX-350-004-M001 |
|
1 mg |
50.00 USD |
|
|
|
ALX-350-004-M005 |
|
5 mg |
200.00 USD |
|
|
|
ALX-350-004-M010 |
|
10 mg |
350.00 USD |
|
|
|
ALX-350-004-M025 |
|
25 mg |
690.00 USD |
|
|
|
|
Tunicamycin |
|
|
ALX-380-047-M010 |
|
10 mg |
82.00 USD |
|
|
|
ALX-380-047-M050 |
|
50 mg |
350.00 USD |
|
|
|
|
Monoclonal Antibody to PDI (RL90) |
|
|
ALX-804-012-R100 |
|
100 µl |
379.00 USD |
|
|
|
